Literature DB >> 31780062

Outcomes after endovascular versus open thoracoabdominal aortic aneurysm repair: A population-based study.

Rodolfo V Rocha1, Thomas F Lindsay2, Peter C Austin3, Mohammed Al-Omran4, Thomas L Forbes2, Douglas S Lee5, Maral Ouzounian6.   

Abstract

OBJECTIVE: We sought to determine the early and late outcomes of endovascular versus open thoracoabdominal aortic aneurysm repair.
METHODS: We performed a multicenter population-based study across the province of Ontario, Canada, from 2006 to 2017. The primary end point was mortality. Secondary end points were time to first event of a composite of mortality, permanent spinal cord injury, permanent dialysis, and stroke, the individual end points of the composite, patient disposition at discharge, hospital length of stay, myocardial infarction, and secondary procedures at follow-up.
RESULTS: A total of 664 adults undergoing surgical repair of a thoracoabdominal aortic aneurysm (endovascular: n = 303 [45.5%] vs open: n = 361 [54.5%]) were identified using an algorithm of administrative codes validated against the operative records. Propensity score matching resulted in 241 patient pairs. Endovascular repairs increased during the study and currently comprise more than 50% of total repairs. In the matched sample, open repair was associated with a higher incidence of in-hospital death (17.4% vs 10.8%, P = .04), complications (26.1% vs 17.4%, P = .02), discharge to rehabilitation facilities (18.7% vs 10.0%, P = .02), and longer length of stay (12 [7-21] vs 6 [3-13] days, P < .01). Long-term mortality was not significantly different (hazard ratio, 1.09; 95% confidence interval, 0.78-1.50), nor were the other secondary end points, with the exception of secondary procedures, which were higher in the endovascular group (hazard ratio, 2.64; 95% confidence interval, 1.54-4.55). At 8 years, overall survival was 41.3% versus 44.6% after endovascular and open repair (P = .62).
CONCLUSIONS: Endovascular repair was associated with improved early outcomes but higher rates of secondary procedures after discharge. Long-term survival after thoracoabdominal aortic aneurysm repair is poor and independent of repair technique.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  population-based; survival; thoracoabdominal aortic aneurysm

Year:  2019        PMID: 31780062     DOI: 10.1016/j.jtcvs.2019.09.148

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

Review 1.  Endovascular versus conventional open surgical repair for thoracoabdominal aortic aneurysms.

Authors:  Sherif Sultan; Jamie Concannon; Dave Veerasingam; Wael Tawfick; Peter McHugh; Fionnuala Jordan; Niamh Hynes
Journal:  Cochrane Database Syst Rev       Date:  2022-04-01

Review 2.  Fenestrated and Branched Stent-Grafts for the Treatment of Thoracoabdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis.

Authors:  Zhongzhou Hu; Zheng Zhang; Hui Liu; Zhong Chen
Journal:  Front Cardiovasc Med       Date:  2022-05-31

Review 3.  Effectiveness of endovascular repair versus open surgery for the treatment of thoracoabdominal aneurysm: A systematic review and meta analysis.

Authors:  Aayat Ellahi; Fahd Niaz Shaikh; Haider Kashif; Hamna Khan; Eman Ali; Bushra Nasim; Mariam Adil; Zunera Huda; Ayesha Liaquat; Muhammad Sameer Arshad
Journal:  Ann Med Surg (Lond)       Date:  2022-09-03

4.  The application of modular multifunctional left heart bypass circuit system integrated with ultrafiltration in thoracoabdominal aortic aneurysm repair.

Authors:  Lingjin Huang; Xuliang Chen; Qinghua Hu; Fanyan Luo; Jiajia Hu; Lian Duan; E Wang; Zhi Ye; Chengliang Zhang
Journal:  Front Cardiovasc Med       Date:  2022-09-21

5.  Commentary: Cerebrospinal fluid drainage: One component of a successful distal aortic surgery program.

Authors:  Marina Ibrahim; Jennifer C-Y Chung; Thomas F Lindsay; Maral Ouzounian
Journal:  JTCVS Tech       Date:  2021-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.